Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes-Reference-Cited by-同舟云学术

Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes

Published:2018-08 Issue:2 Volume:74 Page:157-164
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

McIntosh Andrew G.,Ristau Benjamin T.,Ruth Karen,Jennings Rachel,Ross Eric,Smaldone Marc C.,Chen David Y.T.,Viterbo Rosalia,Greenberg Richard E.,Kutikov Alexander,Uzzo Robert G.

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Rising incidence of small renal masses: a need to reassess treatment effect;Hollingsworth;JNCI J Natl Cancer Inst,2006

3. Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data;Smaldone;Med Care,2017

4. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging;Kutikov;Urology,2006

5. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis;Rothman;J Urol,2009

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracing the evolving dynamics and research hotspots in the kidney neoplasm and nephron sparing surgery field from the past to the new era;Cancer Medicine;2024-06

2. Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature;Kidney Cancer;2024-05-07

3. Incremental value of automatically segmented perirenal adipose tissue for pathological grading of clear cell renal cell carcinoma: a multicenter cohort study;International Journal of Surgery;2024-04-03

4. Active Surveillance of Small Renal Masses in a Large Danish Cohort: Assessing Proficiency in Patient Selection;Journal of Kidney Cancer and VHL;2024-03-28

5. Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients;Urologic Oncology: Seminars and Original Investigations;2024-03